Open AccessP495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY
Author(s) -
Abuasab T.,
Alvarado Y.,
Issa G.,
Islam R.,
Short N.,
Yilmaz M.,
jain N.,
Masarova L.,
Kornblau S.,
Jabbour E.,
Pemmaraju N.,
MontalbanBravo G.,
Pierce S.,
DiNardo C.,
Kadia T.,
Daver N.,
Konopleva M.,
GarciaManero G.,
Ravandi F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844868.29082.72
Subject(s) - medicine , decitabine , venetoclax , regimen , ven , gastroenterology , cohort , refractory (planetary science) , chemotherapy regimen , neutropenia , chemotherapy , febrile neutropenia , leukemia , surgery , chronic lymphocytic leukemia , biochemistry , gene expression , chemistry , physics , computer security , astrobiology , computer science , dna methylation , gene